Filing Details
- Accession Number:
- 0000711377-18-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-28 20:56:59
- Reporting Period:
- 2018-09-26
- Accepted Time:
- 2018-09-28 20:56:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651434 | Edward John Adent | 822 7Th Street, Suite 740 Greeley CO 80631 | President & Ceo | No | Yes | No | No |
Transaction Summary
| Purchased: | 4,300 shares | Avg. Price: $73.58 | Total Value: $316,394.00 |
| Number of Shares After Transactions: | 4,300 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-26 | 4,300 | $73.58 | 4,300 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
